Ensemble docking has proven useful in drug discovery and development. It increases the hit rate by incorporating receptor flexibility into molecular docking as demonstrated on important drug targets including G-protein-coupled receptors (GPCRs). Adenosine A1 receptor (A1AR) is a key GPCR that has been targeted for treating cardiac ischemia-reperfusion injuries, neuropathic pain and renal diseases. Development of allosteric modulators, compounds binding to distinct and less conserved GPCR target sites compared with agonists and antagonists, has attracted increasing interest for designing selective drugs of the A1AR. Despite significant advances, more effective approaches are needed to discover potent and selective allosteric modulators of the A1AR.
Introduction
G-protein-coupled receptors (GPCRs) are the largest family of human membrane proteins. They mediate cellular responses to hormones, neurotransmitters, chemokines and the senses of sight, olfaction and taste. GPCRs have served as the primary targets for about one third of currently marketed drugs [1] [2] [3] . Particularly, the adenosine A1 receptor (A1AR) has emerged as an important therapeutic target for treating cardiac ischemia-reperfusion injuries, neuropathic pain and renal diseases [4] . However, development of the A1AR agonists as effective drugs has been greatly hindered. Several candidates could not progress into the clinic due to low efficacy and/or safety issues related to off-target effects. Four receptor subtypes, the A1, A2A, A2B and A3, share a highly conserved endogenous agonist binding ("orthostatic") site. It is challenging to design effective agonists with high selectivity.
It is appealing to design positive allosteric modulators (PAMs) that bind a less conserved, topographically distinct site and increase the responsiveness of the A1AR to endogenous adenosine in local regions of its production. The first selective PAM of the A1AR, PD81,723, was introduced in 1990 [5, 6] . Since then, many research groups have performed extensive structure-activity relationship studies [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Several refined compounds were identified. Notably, T62 evaluated by King Pharmaceuticals progressed to Phase IIB clinical trial but failed due to lack of potency [16, 17] . Overall, these compounds still suffer from major limitations such as low solubility and potency for pharmaceutical use. It remains difficult to discover PAMs of higher potency for the A1AR.
Virtual screening has become increasingly important in the development of therapeutic drugs and discovery of novel GPCR ligands, including the antagonists, agonists, and allosteric modulators [18, 19] . Molecular docking is a widely used virtual screening technique. Early docking studies were performed using static crystal structures of target receptors and flexible ligands, which were successful in certain cases [20] . However, proteins have been often considered rigid, largely limiting the successful rate of docking. In fact, proteins are usually flexible and involve conformational changes upon ligand binding [21] . Therefore, computational approaches are needed to deal with the flexibility of proteins.
Ensemble docking of small probe molecules for flexible pharmacophore modeling was first introduced in 1999 [21] . Since then, ensemble-based [22] methods has been implemented to identify novel ligands of different proteins [23] , including the immunophilin FKBP [24] , HIV-1 integrase [25] , RNA-editing ligase [26] , membrane fusion protein [27] , prothrombinase enzyme [28] and fibroblast growth factor 23 [29] . Additionally, ensemble docking has been applied to applied interactions between the drug and off-target proteins [30] and identify protein targets of natural products [31, 32] . Furthermore, ensemble docking has been applied to discover novel allosteric modulators of GPCRs. Huang et al. [33] discovered a unique PAM ogerin of GPR68 and allosteric modulators of GPR65 by docking to receptor ensembles generated from homology modeling. Long-timescale accelerated molecular dynamics (aMD) simulations were incorporated into ensemble docking to design allosteric modulators of the M2 muscarinic GPCR [34] . A number of 12 compounds with affinities ≤ 30 µM was identified, four of which were confirmed as new negative allosteric modulators (NAMs) and one as a PAM of the M2 receptor.
For the A1AR, X-ray structures have been determined in the inactive antagonist-bound form [35] and a cryo-EM structure in the active agonist-Gi-bound complex [36] . However, there is still no published structure of the A1AR bound by allosteric modulators. This has greatly hindered structure-based design of potent and selective PAMs of the A1AR [37] . Nevertheless, mutagenesis and molecular modeling studies have suggested that the A1AR allosteric site may reside within the second extracellular loop (ECL2) [38, 39] . We previously applied Gaussian accelerated molecular dynamics (GaMD) simulations to determine binding modes of two prototypical A1AR PAMs, PD81723 and VCP171 [40] . The GaMD simulations allowed us to identify low-energy binding modes of the PAMs at an allosteric site formed by the receptor ECL2, being highly consistence with the experimental data [38, 39] . Additionally, we performed GaMD simulations on both the inactive antagonist-bound and active agonist-Gi-bound A1AR [41, 42] .
The GPCR-membrane interactions were found to highly depend on the receptor activation state and motions in the GPCR and membrane lipids are strongly coupled [41] . These studies provided an excellent starting point for ensemble docking and rational drug design of the A1AR. In this study, structural ensembles were generated from GaMD simulations of the A1AR and used for retrospective docking of allosteric modulators ( Fig. 1 and 2A) . Receptor snapshots were taken every 0.2 ps from the GaMD simulations and clustered for the ECL2 target site. Ten representative structural clusters were obtained for molecular docking. We performed retrospective docking of 25 known PAMs of the A1AR [15, [43] [44] [45] [46] and 2475 drug-like decoys generated from the Directory of Useful Decoys, Enhanced (DUD-E) [47] . Autodock was applied for both rigid-body and flexible docking [48] [49] [50] . Enrichment factors (EFs) [51] and area under the receiver operating characteristic curve (AUC) were calculated to evaluate the docking performances. Retrospective docking of the PAMs allowed us to validate structural ensembles of the A1AR and optimize our molecular docking protocol for future virtual screening.
Materials and Methods

Gaussian accelerated Molecular Dynamics (GaMD)
GaMD is an enhanced sampling technique, in which a harmonic boost potential is added to reduce the system energy barriers [52] . GaMD is able to accelerate biomolecular simulations by orders of magnitude [53, 54] . GaMD does not need predefined collective variables. Moreover, because GaMD boost potential follows a Gaussian distribution, biomolecular free energy profiles can be properly recovered through cumulant expansion to the second order [52] . GaMD has successfully overcome the energetic reweighting problem in free energy calculations that was encountered in the previous accelerated molecular dynamics (aMD) method [55, 56] for free energy calculations.
GaMD has been implemented in widely used software packages including AMBER [52, 57] and NAMD [58] . A brief summary of GaMD is provided here. 
where k is the harmonic force constant. The two adjustable parameters E and k are automatically determined based on three enhanced sampling principles [52] . The reference energy needs to be set in the following range:
where Vmax and Vmin are the system minimum and maximum potential energies. To ensure that and standard deviation of the system potential energies, ∆B is the standard deviation of ∆ with J as a user-specified upper limit (e.g., 10kBT) for proper reweighting. When E is set to the lower bound E=Vmax, J can be calculated as:
Alternatively, when the threshold energy E is set to its upper bound = <?@ + & A , J is set to:
if J " is found to be between 0 and 1. Otherwise, J is calculated using Eqn. (3).
Similar to aMD, GaMD provides schemes to add only the total potential boost ∆ Z , only dihedral potential boost ∆ [ , or the dual potential boost (both ∆ Z and ∆ [ ). The dual-boost simulation generally provides higher acceleration than the other two types of simulations [60] . The simulation parameters comprise of the threshold energy E for applying boost potential and the effective harmonic force constants, JZ and J[ for the total and dihedral potential boost, respectively.
Energetic reweighting of GaMD simulations
To calculate potential of mean force (PMF) [61] from GaMD simulations, the probability distribution along a reaction coordinate is written as * ( ) . Given the boost potential ∆ ( ⃑) of each frame, * ( ) can be reweighted to recover the canonical ensemble distribution, ( ), as:
where M is the number of bins, = p and 〈 s∆B(t ⃑) 〉^ is the ensemble-averaged Boltzmann factor of ∆ ( ⃑) for simulation frames found in the j th bin. The ensemble-averaged reweighting factor can be approximated using cumulant expansion:
where the first two cumulants are given by
The boost potential obtained from GaMD simulations usually follows near-Gaussian distribution.
Cumulant expansion to the second order thus provides a good approximation for computing the reweighting factor [52, 59] . The reweighted free energy ( ) = − p ln ( ) is calculated as:
where * ( ) = − p ln * ( ) is the modified free energy obtained from GaMD simulation and
• is a constant.
System setup
The cryo-EM structure of the ADO-A1AR-Gi complex (PDB: 6D9H [36] ) were used to prepare the simulation systems. In order to prepare PAM-bound structures of the active A1AR for docking, the VCP171 was docked with Autodock to the ECL2 allosteric site of the A1AR [38] [39] [40] . Then the binding conformation of VCP171 with the highest docking score was chosen as initial structure of the PAM-bound A1AR. For both PAM-free (apo) and PAM-bound (holo) structures of the A1AR, all chain termini were capped with neutral groups, i.e. the acetyl group (ACE) for the N-terminus and methyl amide group (CT3) for C terminus. Protein residues were set to the standard CHARMM protonation states at neutral pH with the psfgen plugin in VMD [62] . Then the receptor was inserted into a POPC bilayer with all overlapping lipid molecules removed using the Membrane plugin in VMD [62] . The system charges were then neutralized at 0.15 M NaCl using the Solvate plugin in VMD [62] . Periodic boundary conditions were applied on the simulation systems.
The CHARMM36 parameter set [63] was used for the protein and POPC lipids. For agonist ADO and PAM VCP171, the force field parameters were obtained from the CHARMM ParamChem web server [38, 64] . Initial energy minimization and thermalization of the A1AR system follow the same protocol as used in the previous GPCR simulations [65] . The simulation proceeded with equilibration of lipid tails. With all the other atom fixed, the lipid tails were energy minimized for 1000 steps using the conjugate gradient algorithm and melted with constant number, volume, and temperature (NVT) run for 0.5ns at 310 K. Each system was further equilibrated using constant number, pressure, and temperature (NPT) run at 1 atm and 310 K for 10 ns with 5 kcal (mol Å 2 ) -1 harmonic position restraints applied to the protein. Further equilibration of the systems was performed using an NPT run at 1 atm and 310 K for 0.5ns with all atoms unrestrained.
Conventional MD simulation was performed on each system for 10 ns at 1atm pressure and 310 K with a constant ratio constraint applied on the lipid bilayer in the X-Y plane. Both dihedral and dual-boost GaMD simulations (GaMD_Dih and GaMD_dual respectively) were then performed using NAMD2.13 [58, 66] and AMBER 18 [52] to generate receptor ensembles for docking.
Simulations of the A1AR were summarized in Table 1 . In the GaMD simulations, the threshold energy E for adding boost potential is set to the lower bound, i.e. E = Vmax [52, 58] . The simulations included 50ns equilibration after adding the boost potential and then three independent production runs lasting 300 ns with randomized initial atomic velocities. GaMD production simulation frames were saved every 0.2ps. Snapshots of all three GaMD production simulations were combined for clustering to identify representative structures for docking using the hierarchical agglomerative algorithm in CPPTRAJ [67] . The PyReweighting toolkit [59] was applied to reweight GaMD simulations by combining independent trajectories for each system. Free energy values were calculated for the top-ranked structural clusters of the receptor.
Retrospective docking of known allosteric ligands to the A1AR
A number of 25 known PAMs of the A1AR were collected from literature [15, [43] [44] [45] [46] (Fig. 2B) and 2475 decoys were obtained from the DUD-E database [47] . This compound library served as a dataset to validate the receptor ensembles constructed from GaMD simulations of the A1AR.
Docking was performed on these compounds to the receptor ECL2 site using Autodock [48] .
Default parameters (number of individuals in population (ga_pop_size), 1,500; maximum number of generations (ga_num_generations), 27,000 and number of genetic algorithms run (ga_run), 10)
were used for the Autodock docking calculations unless described otherwise. A set of docking algorithms were extensively tested, including the flexible docking and rigid-body docking at different levels (the long level with ga_num_evals of 25,000,000, medium level with ga_num_evals of 2,500,000 and short level with ga_num_evals of 250,000). For the flexible docking, residues within 5 Å of VCP171 in the docking pose were selected as flexible residues.
The representative structures obtained from GaMD simulations and the cryo-EM structure of the A1AR (PDB ID: 6D9H) were used for the receptor. The ADO agonist was kept in all the docking calculations. Firstly, all polar hydrogens were added and Gasteiger charges were assigned to atoms in the receptor. Secondly, a 3D search grid was created with the AutoGrid algorithm [68] to calculate binding energies of the ligands and decoys in the A1AR. The center of mass of the receptor ECL2 was chosen as the grid center and a box size of 60*60*60 Å 3 was applied for docking. The Lamarckian genetic algorithm [68] was applied to model protein-ligand interactions.
For docking of GaMD simulation structural clusters, the predicted binding energy for each conformation was calculated by its raw docking score and reweighted according to the following:
where PMFi is the reweighted free energy of the ith receptor structural cluster and •‚•A is the corresponding raw docking score. Ranking of the docked compounds was examined in terms of both the minimum predicted binding energy obtained for each compound against any of the given receptor structures ("BEmin") and the average of predicted binding energies ("BEavg") [34] . The average binding energy is calculated as:
where Nc is the total number of receptor structural clusters, ? is the binding energy of a compound to the ith cluster. The minimum predicted binding energy is given by:
Enrichment factor (EF) is calculated by:
where the Ntotal, Nsampled, Hits_total and Hits_sampled are the number of total compounds in the database, number of compounds for ranking, number of total hits in the database and number of hits found among the ranked compounds, respectively. The "early" enrichment factor (EF') that accounts for the rank of each of the Hits_sampled known actives is calculated by:
Where the Š=<gOE`• is the average percentile rank of the Hits_sampled known actives.
Results
Construction of receptor ensembles through structural clustering of GaMD simulations
All-atom GaMD simulations were performed on different systems of the active A1AR with varied levels of acceleration, i.e. the dihedral and dual boost (see Methods and Table 1 ). Two different software packages, NAMD2.13 [58, 66] and AMBER 18 [52, 57] were used for the simulations.
Six sets of GaMD simulations, including the ADO-A1AR-Gi (NAMD, GaMD_Dih), ADO-A1AR-Gi (NAMD, GaMD_Dual), ADO-A1AR-Gi (AMBER, GaMD_Dih), ADO-A1AR-Gi (AMBER, GaMD_Dual), ADO-A1AR-Gi-VCP171 (AMBER, GaMD_Dih) and ADO-A1AR-Gi-VCP171
(AMBER, GaMD_Dual) were obtained to generate receptor ensembles. Overall, GaMD_Dual provided higher boost potential than the GaMD_Dih. AMBER provided higher boost potential than NAMD in the GaMD simulations due to different algorithms used to calculate the potential average and standard deviation [40] . and their sampled conformational space ( Table 2) . Overall, the top clusters in each receptor ensemble contributed to significantly higher fractions of simulation frames than the lower ranked clusters. However, the free energy values were ordered differently for most of the structural clusters with GaMD reweighting. It was thus important to take GaMD reweighted free energies into account in the ensemble docking. Notably, structural clusters obtained from AMBER GaMD_Dual simulations of ADO-A1AR-Gi-VCP171 system sampled the largest conformational space, as characterized by ~4.5-5.9 Å average distance between the cluster centroids (AvgCDist) and 2.31 Å average distance between simulation frames (AvgDist) of the lowest free energy/topranked cluster ( Table 2 ). In comparison, clusters from AMBER GaMD_Dih simulations of the VCP171-bound A1AR sampled the smallest conformational space with ~2.1-2.4 Å average cluster centroid distance and 1.78 Å average distance between simulation fames in the top cluster. Clusters obtained from GaMD simulations of the ADO-A1AR-Gi system sampled conformational space in the medium range (Table 2) . These receptor structural ensembles were subsequently used for retrospective docking of PAMs in the A1AR.
Correction with GaMD reweighting improved retrospective docking performances
The GaMD receptor ensembles were used for docking of the compound library consisting of 25
known PAMs and 2475 decoys of the A1AR. The EF and EF' enrichment factors and AUC values were calculated to evaluate the ensemble docking performances [51] . The EF and EF' were calculated for top 5% and 10% of total sampled compounds ( Table 3) . For the ten representative conformations obtained from each set of GaMD simulations, both the minimum binding energy ( <?@ ) and the average binding energy ( =MN ) were used to assess the docking performances. To evaluate the effects of GaMD reweighting, we compared the binding energies using both the raw scores obtained from docking calculations ("raw" in Table 3 ) and the reweighted scores corrected with cluster free energy values calculated by GaMD reweighting ("reweighted" in Table 3 ). For a total of 60 calculated docking metrics regarding the AUC, EF (5%), EF (10%), EF' (5%) and
EF' (10%) as listed in Table 3 , 32 (53.3%) of them showed better performance using the GaMDreweighted scores than using the raw scores. While only 10 (16.7%) of them showed decreased performance and 18 (30%) with the same performance ( Table 3) .
With GaMD reweighting, the calculated AUC using ranking by the minimum binding energy ( <?@ ) increased by ~10-14% for receptor ensembles obtained from NAMD GaMD_Dih, NAMD GaMD_Dual and AMBER GaMD_Dih simulations of the ADO-A1AR-Gi system. The AUC using ranking by the average binding energy ( =MN ) increased from 0.44 to 0.61 for receptor ensemble from AMBER GaMD_Dih of the ADO-A1AR-Gi system. More importantly, while the EF and EF' values for 5% of sampled compounds were generally small for both raw and reweighted docking scores, the EF and EF' for 10% of sampled compound increased significantly with reweighted scores for receptor ensembles of all the simulations ( Table 3) . This would be more relevant for drug design projects since only top ranked compounds could often be tested in experiments. Therefore, binding energies corrected by GaMD reweighting improved the docking performances.
Furthermore, we compared the calculated AUC, EF and EF' in terms of ranking using the minimum binding energy ( <?@ ) and average binding energies ( =MN ) . Although with exceptions, the usage of =MN mostly outperformed that of <?@ , especially in the calculated EF' (5%) and EF' (10%) ( Table 3) . Notably, the EF'(5%) increased by ~70% to 7 times using =MN in ensemble docking of the ADO-A1AR-Gi system from the NAMD GaMD_Dih, NAMD GaMD_Dual and AMBER GaMD_Dih simulations than using the <?@ , and ~2-5 times for the EF'(10%) ( Table 3 ). The average predicted binding energy ( =MN ) was thus applied for further parameter testing of the docking calculations.
Flexible docking performed better than different levels of rigid-body docking
Next, we compared the performances of flexible docking and different levels of rigid-body docking with Autodock ( Table 4 ). In a total of 30 calculated docking metrics regarding the AUC, EF(5%), EF(10%), EF'(5%) and EF'(10%), 22 (73.3%) of them showed improved performance with flexible docking compared with rigid-body docking at the short, medium and long levels, while only 2 (6.7%) showed the same performance and 6 (20%) with decreased performance.
Among the 22 metrics that showed improved performance with flexible docking, 17 of these values increased by more than 2 times compared with rigid-body docking ( Table 4) .
The AUC increased with flexible docking of all the receptor ensembles except the ADO-A1AR-Gi ensemble from the AMBER GaMD_Dih and GaMD_Dual simulations ( Table 4) respectively, compared to the latter ( Table 5) . It is worth noting that the performance of docking the PAMs in the current study was relatively lower than that of the orthosteric ligands that bind inside class A GPCRs with generally higher affinities [34] . Nonetheless, with GaMD simulations and flexible docking, we have optimized our ensemble docking protocol to effectively account for the receptor flexibility, which will facilitate virtual screening of PAMs for the A1AR.
Discussion
In this study, we have carried out extensive retrospective docking calculations of PAM binding to the A1AR using GaMD enhanced simulations and AutoDock. The GaMD simulations have been performed using the AMBER and NAMD simulation packages at different acceleration levels (dihedral and dual boost). The rigid-body docking at different short, medium and long levels and flexible docking have been all evaluated in our ensemble docking protocol.
Overall, flexible docking performed significantly better than the rigid-body docking at different levels with AutoDock. This suggested that the flexibility of protein side chains in ensemble docking is also important. The side chains of representative receptor structures obtained from GaMD simulations might be still in unfavored conformations for PAM binding. Flexible docking of protein side chains could then alleviate this problem to achieve better performance. The Glide induced fit docking was also found to outperform rigid-body docking in a previous study to identify allosteric modulators of the M2 muscarinic GPCR [34] . Generally speaking, flexible docking greatly helps accounting for protein flexibility in the side chains and improves docking performances [69] .
To fully account for the protein flexibility, especially the backbone, we further incorporated GaMD enhanced sampling simulations in an ensemble docking protocol (Fig. 1) . In the GaMD simulations, the boost potential obtained for one system with AMBER was greater than with NAMD due to different algorithms used to calculate the system potential statistics [40] . 
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